We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Osteoporosis drug

News List

Italy gives approval to trial osteoporosis drug for Covid-19 treatment pharmaceutical-technology
October 29, 2020
The Italian Medicines Agency (AIFA) has granted approval to conduct human clinical trials on raloxifene, a generic osteoporosis drug to treat paucisymptomatic Covid-19 patients.
FDA panel backs Amgen, UCB's postmenopausal osteoporosis drug Evenity firstwordpharma
January 17, 2019
An FDA advisory panel on Wednesday voted 18-1 that the benefits of Amgen and UCB's monthly injection Evenity (romosozumab) outweigh its risks for the treatment of osteoporosis in postmenopausal women at high risk for fracture.
Osteoporosis drug may benefit heart health europeanpharmaceuticalreview
May 16, 2018
The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack and stroke…